Fosun Pharma USA Inc. - 05 Jun 2025 Form 3 Insider Report for NATURES SUNSHINE PRODUCTS INC (NATR)

Role: 10%+ Owner
Signature: Fosun Pharma USA Inc. By: /s/ Yuqing Wang, Chief Financial Officer
Issuer symbol: NATR
Transactions as of: 05 Jun 2025
Net transactions value: $0
Form type: 3
Filing time: 09 Jun 2025, 16:32:08 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Fosun Pharma USA Inc.	10%+ Owner	104 CARNEGIE CENTER DRIVE, SUITE 204, PRINCETON	Fosun Pharma USA Inc. By: /s/ Yuqing Wang, Chief Financial Officer	09 Jun 2025	0002071437

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NATR	Common Stock						2,854,607	05 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. transferred these shares to its wholly-owned subsidiary, Fosun Pharma USA Inc. Following the transfer, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Fosun Pharma USA Inc. intend to jointly file Section 16 reports with respect to these shares.